3
Announcements
Trials
Browse
Landscape
Status
No longer available
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Plasma cell
2
Thoracic
1
Lymphoid
1
Conditions
Carcinoma, Non-Small-Cell Lung
13
Lung Neoplasms
6
Small Cell Lung Carcinoma
2
Prostatic Neoplasms
2
Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma
2
Adenocarcinoma of Lung
2
Thyroid Neoplasms
1
Thoracic Neoplasms
1
Squamous Non-Small Cell Lung Cancer
1
Sarcoma, Synovial
1
Sarcoma
1
Rhabdoid Tumor
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Non Small Cell Lung Cancer ALK Positive or ROS1 Positive
1
Neoplasms by Site
1
Mesothelioma, Malignant
1
Melanoma
1
Lymphoma, Large-Cell, Anaplastic
1
Lung Diseases
1
Granuloma, Plasma Cell
1
Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer
1
EGFR T790M Mutation Positive NSCLC
1
Desmoplastic Small Round Cell Tumor
1
Colorectal Neoplasms
1
Chondrosarcoma
1
Interventions
ceritinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
No longer available
×
Granuloma, Plasma Cell
×
Thoracic
×
Clear all
NCT05100134
2026-04-01
Managed Access Programs for LDK378, Ceritinib
Novartis
No longer available